Extracellular matrix in tumours as a source of additional neoplastic lesions - a review

Abstract

The review describes the role of cells of extracellular matrix (ECM) as a source of neoplastic outgrowths additional to the original tumour. The cells undergo a spontaneous transformation or stimulation by the original tumour through intercellular signals, e.g. through Shh protein (sonic hedgehog). Additionally, cells of an inflammatory infiltrate, which frequently accompany malignant tumours and particularly carcinomas, may regulate tumour cell behaviour. This is either by restricting tumour proliferation or, inversely, by induction and stimulation of the proliferation of another tumour cell type, e.g. mesenchymal cells. The latter type of tumour may involve formation of histologically differentiated stromal tumours (GIST), which probably originate from interstitial cells of Cajal in the alimentary tract. Occasionally, e.g. in gastric carcinoma, proliferation involves lymphoid follicles and lymphocytes of GALT (gut-associated lymphoid tissue), which gives rise to lymphoma. The process is preceded by the earlier stage of intestinal metaplasia, or is induced by gastritis alone. This is an example of primary involvement of inflammatory infiltrate cells in neoplastic progression. Despite the numerous histogenetic classifications of tumours (zygotoma benignum et zygotoma malignum, or mesenchymomata maligna et mesenchymomata benigna), currently in oncological diagnosis the view prevails that the direction of tumour differentiation and its degree of histologic malignancy (grading) are more important factors than the histogenesis of the tumour.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Akoluk A.A., Barazani Y., Slova D., Shah S., Tarren B.: Carcinosarcoma of the bladder: case report and reviev of the literature. Canad Urol Assoc J 2011, 5, 69-73.

  • 2. Almes K.M., Heaney A.M., Anderews G.A.: Intracardiac ectopic thyroid carcinoma in dog. Vet Pathol 2008, 45, 500-504.

  • 3. Baines C.P.: Role of the mitochondrium in programmed necrosis. Front Physiol 2011, 1, 156-164.

  • 4. Brocker C., Vasiliou V., Nebert D.W.: Evolutionary divergence and functions of the ADAM and ADAMS gene families. Human Genomics 2009, 4, 43-55.

  • 5. Del Carmen M.G., Birrer M., Schorge J.O.: Carcinosarcoma of thy ovary: a review of the literature. Gynec Oncol 2012, 125, 271-277.

  • 6. Cirocci R., Trastulli S., Desiderio J., Grassi V., Barillaro I., Santoro A., Boselli C., Avena N., Noya G., De Sol A.: Gastric carcinosarcoma. A case report and review of the literature. Oncol Lett 2012, 4, 53-58.

  • 7. Cirri P., Chiarugi P.: Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012, 31, 195-208.

  • 8. Edwards D.R., Handsley M.M., Pennington C.J.: The ADAM metalloproteinases. Mol Aspects Med 2008, 29, 258-289.

  • 9. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R.: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996, 107, 404-411.

  • 10. Farell R.J., Kelley C.P.: Celiae sprue. N Engl J Med 2002, 346, 180-188.

  • 11. Gelos M., Behringer D., Philippou S., Mann B.: Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature. JOP J Pancreas 2008, 9, 50-55.

  • 12. Grubor B., Haynes J.S.: Thyroid carcinosarcoma in a dog. Vet Pathol 2005, 42, 84-87.

  • 13. Hanahan D., Weiberg R.A.: Hallmarks of cancer: the next generation. Cell 2011, 144, 646-674.

  • 14. Kaczanowski A., Kaczanowska J.: Mechanisms of embryonic spatial differentiation. Post Biol Kom 2001, 28, 69-98.

  • 15. Kawiak J., Zabel M.: Seminars cytophysiology. Urban & Partner, Wrocław, 2002.

  • 16. Klimek R., Madej J.A., Sieroń A.: Cancer - tumors and neoplastic disease. Editor R. Klimek, Kraków 2006.

  • 17. Lacroix M., Leclecq G.: Relevance of breast cancer cell lines as models for breast tumours: an update. Brest Cancer Res Treat 2004, 83, 249-280.

  • 18. Madej J.A.: Pathomorphology of cumulative and proliferative non-neoplastic lesions in extracellular matrix. Med Weter 2008, 64, 977-983.

  • 19. Madej J.A.: Outline of the natural history of tumours. Med Weter 2012, 68, 259-264.

  • 20. Nyberg P., Salo T., Kalluri R.: Tumor microenvironment and angiogenesis. Front Biosci 2008, 13, 6537-6553.

  • 21. Rumi E., Passamonit F., Della Porta M.G., Elena C., Arcaini L., Vanelli L., Del Curto C., Pietra D., Pascutto C., Cazzola M., Lazzarino M.: Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. J Clin Oncol 2007, 25, 5630-5635.

  • 22. Sawicki W., Malejczyk J.: Histology. PZWL, Warszawa, 2012.

  • 23. Schwartz E.P., Kelly M.G.: Malignant transformation of myomas: myth or reality? Obstet Gynecol Clin N Am 2006, 33, 183-198.

  • 24. Sica A., Allavena P., Mantovani A.: Cancer related inflammation: the macrophage connection. Cancer Lett 2008, 267, 204-215.

  • 25. Sokucu S.N., Kocaturk C., Urer N., Sonmezoglu Y., Dalar L., Karasulu L., Altin S., Bedirhan M.A.: Evaluation of six patients with pulmonary carcinosarcoma with a literature review. Sci World J 2012, 10, 1-5.

  • 26. Stachura J., Domagała W.: Pathology - word about the disease. Vol II. General Pathology. PAU, Kraków, 2003.

  • 27. St Croix B., Rago C., Velcukscu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W.: Gene expressed in human tumor endothelium. Science 2000, 289, 1197-1202.

  • 28. Szala S., Radzikowski C.: Molecular basis of cancer angiogenesis. Nowotwory 1997, 41, 1-20.

  • 29. Szlosarek P.W., Balkwill F.R.: Tumour necrosis factor alpha: a potential target for the therapy of solid tumors. Lancet Oncol 2003, 4, 565-573.

  • 30. Vallee R.B., Sheetz M.P.: Targeting of motor proteins. Science 1996, 271, 1539-1545.

  • 31. Vineis P., Schatzkin A., Potter J.D.: Models of cancerogenesis: an overview. Carcinogenesis 2011, 31, 1703-1709.

  • 32. Xie K., Huang S.: Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis 2003, 20, 31-43.

  • 33. Yamaguchi Y., Yashikawa K.: Cutaneous wound healing: an update. J Dermatol 2001, 28, 521-531.

  • 34. Yamanchi N., Harada T., Tanigucki F., Yoshida S., Iwabe T., Terakawa N.: Tumor necrosis factor-α induced the relase o interleukin - 6 from endometriotic stromall cells by the nuclear factor - kB and mitogen activated protein kinase pathways. Fert Steril 2004, 82 (suppl), 1023-1028.

  • 35. Zarębski A.: Some inhibitors of intracellular signal transduction in the inhibition of cytokines synthesis. Post Biol Kom 2001, 28 (suppl), 15-22.

  • 36. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., Triggvason K., Reeders S.T.: Deletion of the paired alfa 5 (IV) and alfa 6 (IV) collagen genes in inherited smooth muscle tumors. Science 1993, 261, 1167-1169.

OPEN ACCESS

Journal + Issues

Search